Lipid management

Slides (presentation) - Apr. 7, 2011

Cholesterol Lowering and CV Risk: Meta-analyses - 8 slides

The second cycle of the Cholesterol Treatment Trialists’ (CTT) Collaboration consisted of 2 parts: a meta-analysis of more versus less intensive statin therapy and an updating of the first cycle meta-analysis of statin versus control that added 7 more trials.

2. Stroke and CV Risk in Asia. lipid lowering meta analysis (PPTX 365KB)

Preview slide presentation - click on pictures

Cholesterol Lowering and CV Risk: Meta-analyses

On-Treatment LDL and CHD Events in Statin Trials

Second Cycle of the CTT Meta-analysis: Proportional Effects on Major VascularEvents Per Mmol/L LDL-C Reduction

Second Cycle of the CTT Meta-analysis:More vs Less Statin—Proportional Effects onMajor Vascular Events Per Mmol/L LDL-C Reduction

Second Cycle of the CTT Meta-analysis: Statin vs Control—Proportional Effects onMajor Vascular Events Per Mmol/L LDL-C Reduction

Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke

Meta-analysis of Statin Trials and Stroke Mortality

Stroke Risk and LDL Lowering inStatin Trials